| Literature DB >> 35811815 |
Dulce María Moreno-García1, Deyanira Ojeda-Ramírez1, Monica Salas-Rojas2, Eduardo Fernández-Martínez3, Ma Del Rocío López-Cuellar4, Carolina G Sosa-Gutierrez1, Armando Peláez-Acero1, Nallely Rivero-Perez1, Adrian Zaragoza-Bastida1.
Abstract
Sea urchins are a group of benthic invertebrates characterized by having rigid globose bodies, covered in spines, and have an innate immune system that has allowed them to survive in the environment and defend against many pathogens that affect them. They are consumed for their unique flavor, but also for possessing a rich source of bioactive compounds which make them a source for a wide array of medicinal properties. Thus, these may be used to discover and develop new drugs such as anti-bacterials, anti-carcinogenics and anti-virals. Precisely for those reasons, this revision is centered on the known biological activities in various sea urchin species. Recently, the potential pharmacological benefits of nine sea urchin species [Diadema antillarum (Philippi 1845), Echinometra mathaei (de Blainville), Evechinus chloroticus (Valenciennes), Mesocentrotus nudus (Agassiz, 1863), Paracentrotus lividus (Lamarck, 1816), Scaphechinus mirabilis (Agazzis, 1863), Stomopneustes variolaris (Lamarck, 1816), Tripneustes depressus (Agassiz, 1863), and Tripneustes ventricosus (Lamarck, 1816)] have been evaluated. Our work includes a comprehensive review of the anti-fungal, anti-parasitic, anti-inflammatory, hepatoprotective, anti-viral, anti-diabetic, anti-lipidemic, gastro-protective and anti-cardiotoxic effects. Furthermore, we revised the compounds responsible of these pharmacological effects. This work was intended for a broad readership in the fields of pharmacology, drugs and devices, marine biology and aquaculture, fisheries and fish science. Our results suggest that organic extracts, as well as pure compounds obtained from several parts of sea urchin bodies are effective in vitro and in vivo pharmacological models. As such, these properties manifest the potential use of sea urchins to develop emergent active ingredients.Entities:
Keywords: Bioactive compounds; Echinoderms; Naftoquinones; PUFAs; Sea urchin; Terpenes
Year: 2022 PMID: 35811815 PMCID: PMC9261939 DOI: 10.7717/peerj.13606
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 3.061
Figure 1Pharmacological activities of parts of sea urchins.
Biological activities of sea urchins.
| Specie | Extract/compound | Biological activity | Assay | Important results | References |
|---|---|---|---|---|---|
|
| Whole body dichloromethate extract | Antifungal | Disc diffusion | Inhibition zones of 13 to 18 mm against |
|
|
| Extracts obtained with PBS from the spine and test | Antiparasitic | Protoscolices viability test. | 93.33% protococci killed |
|
|
| Crude extract and fractionated naphtoquinones pigments from spines and test | Anti-inflammatory | Cotton pellet-induced granuloma in adult male Sprague-Dawley rats | 12% to 52% inhibition of mouse granuloma. |
|
|
| Lyophilized gonads | Antilipidemic | Mice with hyperlipidemic diet | Stabilization of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in serum, as well as liver weight and visceral fat reduction. |
|
|
| Methanolic extracts obtained from the soft tissues (gonad, mouth and intestine) | Antidiabetic | Streptozotocin induced Diabetes mellitus type 1 and 2 in rats | Gonads and intestine extracts were capable to reduce blood glucose concentrations in rats with DMT1 and DMT2 by values ranging between 138.67 and 180.33 mg/dL, respectively | |
| Echinochrome A isolated from test and spines | Antilipidemic | Male rats with hyper-caloric diet | Levels of lipids, AST and ALT were normalized. |
| |
| Hepatoprotective | Acute sepsis lesions induced by cecal ligation and puncture method in male rats | Decrease of serum concentration of liver damage markers |
| ||
| Echinochromes | Gastroprotective | Induction of severe gastric ulcers in rats | Decrease of gastric juice volume (45%) and acidity of gastric juice. |
| |
|
| Echinochrome A | Anti-cardiotoxic | Quantitative fluorescence assay with CellTox Green cytotoxic assay | Prevents cardiotoxic-induced cell death in H9c2 cardiac myoblast cells in mice |
|
| Aqueous extracts from viscera and spines | Antidiabetic | 19.41–42.46% of inhibition |
| ||
|
| Diterpenoid isolated from the gonads | Anti-inflammatory | IC50 = 2.37 and 2.01 mM for COX-2 and LOP-5, respectively |
| |
|
| Thermostable fractions of coelomic fluid | Antiviral | Viral inhibition test | 74% inhibition for Suid herpesvirus type 1 and 99% inhibition of rabies virus activity at 0.7 IU/mL |
|
|
| Ethanolic extract of the mix of soft tissus | Antifungal | Broth microdilution | 50% inhibition against |
|
Figure 2Chemical structures of compounds isolated from several sea urchins.
(A) 6-ethyl-2,3,5,7,8-pentahydroxy-1,4-naphthoquinone (Echinochrome A). (B) Gallic acid. (C) Chlorogenic acid. (D) 4-hydroxyl-1-(16-methoxiprop-16-en-15-yl)-8-methyl-21, 22-dioxatricyclo [11.3.1.15,8] octadecane-3,19-dione. (E) 2,3,5,7-Tetrahydroxy-1,4-naphthoquinone (Spinochrome B). (F) 2,3,5,6,7,8-Hexahydroxy-1,4-naphthalenedione (Spinochrome E). (G) 3-Acetyl-2,5,7,8-tetrahydroxy-1,4-naphthoquinone (Spinochrome A).